Back

Comparison of baseline characteristics of population in france LEADLESS Registry and first ventricular leadless pacemaker implants in US

13 April 2026 (08:00 - 18:15)
Organised by: Logo
Congress Presentation Part of: Poster session (2): device therapy Antibradycardia Pacing EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Professor Serge Boveda

Clinic Pasteur, Toulouse (France)

210 More presentations in this session

Presentation thumbnail
Genetic variants and device upgrade in young pacemaker recipients
Doctor J. Sanchez Moreno (Almeria, ES)
Abstract Slides Video
Presentation thumbnail
Electrocardiographic repolarization changes following conduction system pacing in pacemaker-induced cardiomyopathy
Doctor A. Sahin (Konya, TR)
Abstract Slides Video
Presentation thumbnail
Experiences with implantable loop recorders in syncope patients
Mr A. Oinonen (Helsinki, FI)
Abstract Slides Video
Presentation thumbnail
Forcecardiography as a non-invasive predictor of echocardiographic parameters in patients undergoing cardiac resynchronization therapy: a preliminary study
Doctor V. Pergola (Naples, IT)
Abstract
Presentation thumbnail
Diagnostic work-up and clinical characteristics in out-of-hospital cardiac arrest survivors with ICD implantation: a prospective Danish study
Mr C. Hansen (Copenhagen, DK) Doctor B. Winkel (Copenhagen, DK)
Abstract

Access the full session

Session thumbnail
Poster session (2): device therapy

The Event

Event poster

EHRA 2026

13 April 2026 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Leadless pacemaker implantation following transvenous lead extraction: data from i-LEAPER registry
17 April 2023
thumbnail
Congress Presentation
Epidemiology of heart failure in young adults and impact of socioeconomic status: a French nationwide cohort study
20 May 2023
thumbnail
Congress Presentation
The use of wearable cardioverter defibrillator in France
1 September 2019
thumbnail
Congress Presentation
Preliminary results of the France LEADLESS study. A safety and effectiveness monitoring of a new ventricular leadless pacemaker.
31 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources